Showing results (171-180 of 863) with videos related to
Sort By:
Pageof 87
Circulation Research|April 30, 2016
Evolving Treatments for Arterial and Venous Thrombosis: Role of the Direct Oral AnticoagulantsNoel C Chan, John W Eikelboom, Jeffrey I WeitzThrombosis and Haemostasis|January 12, 2013
Zinc: an important cofactor in haemostasis and thrombosisTrang T Vu, James C Fredenburgh, Jeffrey I WeitzChest|February 9, 2012
New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesJeffrey I Weitz, John W Eikelboom, Meyer Michel SamamaBMC Cardiovascular Disorders|March 9, 2019
Hypercoagulability and the risk of recurrence in young women with myocardial infarction or ischaemic stroke: a cohort studyAlberto Maino, Ale Algra, Flora Peyvandi, et al.International Journal of Molecular Sciences|February 23, 2019
Understanding the Impact of Aberrant Splicing in Coagulation Factor V DeficiencyElvezia Maria Paraboschi, Marzia Menegatti, Flora Peyvandi, et al.Blood Reviews|June 24, 2019
Evolution of replacement therapy for von Willebrand disease: From plasma fraction to recombinant von Willebrand factorFlora Peyvandi, Peter Kouides, Peter L Turecek, et al.Plos One|February 16, 2022
Worldwide SARS-CoV-2 haplotype distribution in early pandemicAndrea Cairo, Marilena V Iorio, Silvia Spena, et al.Plos One|August 8, 2015
Hypercoagulability Is a Stronger Risk Factor for Ischaemic Stroke than for Myocardial Infarction: A Systematic ReviewAlberto Maino, Frits R Rosendaal, Ale Algra, et al.Fertility and Sterility|November 9, 2005
Disorders of hemostasis and excessive menstrual bleeding: prevalence and clinical impactAndrea S Lukes, Rezan A Kadir, Flora Peyvandi, et al.Human Mutation|October 23, 2009
ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpuraLuca A Lotta, Isabella Garagiola, Roberta Palla, et al.Pageof 87